Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors

被引:96
|
作者
Sunderkoetter, C. [1 ]
Herrgott, I. [1 ]
Brueckner, C. [2 ]
Moinzadeh, P. [3 ]
Pfeiffer, C. [4 ]
Gerss, J. [5 ]
Hunzelmann, N. [3 ]
Boehm, M. [1 ]
Krieg, T. [3 ]
Mueller-Ladner, U. [6 ]
Genth, E. [7 ]
Schulze-Lohoff, E. [8 ]
Meurer, M. [4 ]
Melchers, I. [9 ]
Riemekasten, G. [2 ]
机构
[1] Univ Munster, Dept Dermatol, D-48149 Munster, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Univ Cologne, Dept Dermatol & Venerol, Cologne, Germany
[4] Dresden Univ Hosp, Dept Dermatol, Dresden, Germany
[5] Univ Munster, Coordinating Ctr Clin Trials, Dept Med Informat & Biomath, D-48149 Munster, Germany
[6] Univ Giessen, Kerckhoff Clin, Dept Rheumatol & Clin Immunol, Bad Nauheim, Germany
[7] Univ Aachen, D-5100 Aachen, Germany
[8] Hosp Cologne Merheim, Med Clin 1, Cologne, Germany
[9] Univ Med Ctr Freiburg, Clin Res Unit Rheumatol, Freiburg, Germany
关键词
digital ulcers; German Network; Raynaud's phenomenon; risk factors; systemic sclerosis; RAYNAUDS-PHENOMENON; GERMAN NETWORK; SCLERODERMA TRIALS; ILOPROST TREATMENT; DISEASE; PATHOPHYSIOLOGY; CONSEQUENCES; DERMATOLOGY; MULTICENTER; MANAGEMENT;
D O I
10.1111/j.1365-2133.2008.09004.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Digital ulcers (DU) are a major complication in the course of systemic sclerosis (SSc). In recent years, efficacious, but expensive therapies (e. g. iloprost, sildenafil, bosentan) have been shown to improve healing or to reduce the recurrence of DU. For optimal management it would be useful to identify the risk factors for DU. Such statistical analyses have been rare because they require a high number of patients. Objectives To identify potential risk factors for DU in patients with SSc. Methods We used the registry of the German Network for Systemic Scleroderma and evaluated the data of 1881 patients included by August 2007. We assessed potential risk factors for DU by comparing patients with (24.1%) and without active DU at time of entry (75.9%). Results Multivariate analysis revealed that male sex, presence of pulmonary arterial hypertension (PAH), involvement of the oesophagus, diffuse skin sclerosis (only when PAH was present), anti-Scl70 antibodies, young age at onset of Raynaud's phenomenon (RP), and elevated erythrocyte sedimentation rate (ESR) significantly impacted on the appearance of DU. Certain combinations increased the patients' probability of presenting with DU, with the highest probability (88%) for male patients with early onset of RP, ESR > 30 mm h(-1), anti-Scl70 antibodies and PAH. Patients with DU developed RP, skin sclerosis and organ involvement approximately 2-3 years earlier than patients without DU. Conclusions The results reveal possible risk factors for the occurrence of DU in SSc. As DU are prone to local complications, prophylactic vasoactive treatment for patients presenting with these factors may be justified.
引用
收藏
页码:835 / 843
页数:9
相关论文
共 50 条
  • [1] A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost
    Caramaschi, Paola
    Martinelli, Nicola
    Volpe, Alessandro
    Pieropan, Sara
    Tinazzi, Ilaria
    Patuzzo, Giuseppe
    Mahamid, Helal
    Bambara, Lisa Maria
    Biasi, Domenico
    CLINICAL RHEUMATOLOGY, 2009, 28 (07) : 807 - 813
  • [2] Digital ulcers in patients with systemic sclerosis
    Chung, L
    Fiorentino, D
    AUTOIMMUNITY REVIEWS, 2006, 5 (02) : 125 - 128
  • [3] Optimal management of digital ulcers in systemic sclerosis
    Abraham, Shawn
    Steen, Virginia
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 939 - 947
  • [4] Detection of severe digital vasculopathy in systemic sclerosis by colour Doppler sonography is associated with digital ulcers
    Lueders, Susanne
    Friedrich, Stefanie
    Ohrndorf, Sarah
    Glimm, Anne-Marie
    Burmester, Gerd-Ruediger
    Riemekasten, Gabriela
    Backhaus, Marina
    RHEUMATOLOGY, 2017, 56 (11) : 1865 - 1873
  • [5] A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients
    Silva, I.
    Almeida, J.
    Vasconcelos, C.
    AUTOIMMUNITY REVIEWS, 2015, 14 (02) : 140 - 152
  • [6] Digital Ulcers in Systemic Sclerosis
    Hughes, Michael
    Bruni, Cosimo
    Ruaro, Barbara
    Confalonieri, Marco
    Matucci-Cerinic, Marco
    Bellando-Randone, Silvia
    PRESSE MEDICALE, 2021, 50 (01):
  • [7] Digital ulcers in systemic sclerosis
    Hughes, Michael
    Herrick, Ariane L.
    RHEUMATOLOGY, 2017, 56 (01) : 14 - 25
  • [8] Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis
    Botzoris, Vasileios
    Drosos, Alexandros A.
    JOINT BONE SPINE, 2011, 78 (04) : 341 - 346
  • [9] The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil
    Shah, Ami A.
    Schiopu, Elena
    Chatterjee, Soumya
    Csuka, Mary Ellen
    Frech, Tracy
    Goldberg, Avram
    Spiera, Robert
    Peng, Stanford L.
    McBride, Ryan J.
    Cleveland, Jody M.
    Steen, Virginia
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (09) : 1665 - 1671
  • [10] Digital Ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis
    Ahrens, H. C.
    Siegert, E.
    Tomsitz, D.
    Mattat, K.
    March, C.
    Worm, M.
    Riemekasten, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (05) : S142 - S147